That's mentioned several times in the paper. > despite the controversy surrounding its use, treatment with hydroxychloroquine and azithromycin remains a viable

That's mentioned several times in the paper. > despite the controversy surrounding its use, treatment with hydroxychloroquine and azithromycin remains a viable option Also keep in mind there were only 400 people in the treatment group, and the study concedes: > our study reports on outcomes from the first half of 2020, before vaccination became available and before the emergence of new COVID-19 variants. Since that time several drugs, like remdesivir, molnupiravir and nirmatrelvir/ritonavir were approved for the treatment of Covid-19